Proteon Therapeutics Inc. | Mutual Funds
Mutual Funds that own Proteon Therapeutics Inc.
Vanguard Extended Market Index Fund
81,784
0.46%
0
0%
07/31/2018
Vanguard Total Stock Market Index Fund
49,866
0.28%
0
0%
07/31/2018
iShares Micro Cap ETF
25,739
0.15%
0
0.01%
09/06/2018
Fidelity Spartan Extended Market Index Fund
24,275
0.14%
0
0%
07/31/2018
DFA US Core Equity 2 Portfolio
18,561
0.11%
0
0%
04/30/2018
Vanguard Balanced Index Fund
11,000
0.06%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
5,515
0.03%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
4,121
0.02%
0
0%
09/06/2018
Fidelity Nasdaq Composite Index
2,550
0.01%
0
0%
07/31/2018
2,086
0.01%
0
0.02%
09/05/2018
| Address |
200 West Street
Waltham Massachusetts 02451
United States
|
|
Employees
|
- |
| Website |
http://www.proteontherapeutics.com |
| Updated |
07/08/2019 |
| Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. |
